Results 251 to 260 of about 927,276 (294)

Endogenous Inhibitors of Angiogenesis

Cancer Research, 2005
Abstract Angiogenesis, the formation of new blood vessels, is required for many pathologic processes, including invasive tumor growth as well as physiologic organ/tissue maintenance. Angiogenesis during development and adulthood is likely regulated by a balance between endogenous proangiogenic and antiangiogenic factors. It is speculated
Pia, Nyberg, Liang, Xie, Raghu, Kalluri
openaire   +2 more sources

Tumor Angiogenesis Inhibitors

Biochemistry (Moscow), 2003
Formation of the blood supply system is a critical step in malignant transformation of neoplasms which results in the penetration of tumor cells into neighboring tissues and metastatic growth. Significant progress in the elucidation of mechanisms underlying tumor angiogenesis and the discovery of a great diversity of biomolecules involved in its ...
S M, Kiselev, S V, Lutsenko, S E, Severin, E S, Severin   +3 more
openaire   +2 more sources

Inhibitors of Tumor Angiogenesis

2008
Inhibitors of Tumor ...
Harris, Adrian L, GENERALI, DANIELE
openaire   +3 more sources

Metalloproteinases and their inhibitors in angiogenesis

Expert Reviews in Molecular Medicine, 2003
Angiogenesis, the formation of new blood vessels from the pre-existing vasculature, is an integral part of physiological processes such as embryonic development, the female reproductive cycle and wound healing. Angiogenesis is also central to a variety of pathologies including cancer, where it is recognised as being crucial for the growth of solid ...
Lafleur, M.A., Handsley, M.M., Edwards, D.R.   +2 more
openaire   +3 more sources

Emoxypine as an inhibitor of angiogenesis

Bulletin of Experimental Biology and Medicine, 1992
The effect of emoxypin on angiogenesis in rabbit cornea in aseptic inflammation induced by intracorneal implantation of a piece of quartz and on the development of the vessels of the chick embryo yolk sac was studied. 1% emoxypin pipetted thrice a day for 10-14 days inhibited corneal neovascularization and reduced the formation of new blood vessels. We
A A, Sologub, S I, Akberova, G G, Ziangirova   +2 more
openaire   +2 more sources

Heparin Derivatives as Angiogenesis Inhibitors

Current Pharmaceutical Design, 2003
Angiogenesis is the process of generating new capillary blood vessels. Uncontrolled endothelial cell proliferation is observed in tumor neovascularization and in angioproliferative diseases. Tumors cannot growth as a mass above few mm(3) unless a new blood supply is induced. It derives that the control of the neovascularization process may affect tumor
PRESTA, Marco, LEALI, Daria, STABILE H., RONCA, Roberto, CAMOZZI M., COCO L., MORONI E., LIEKENS S., RUSNATI, Marco   +8 more
openaire   +2 more sources

CURCUMIN AS AN INHIBITOR OF ANGIOGENESIS

2007
Angiogenesis, the formation of new blood vessels from host vasculature, is critical for tumor growth and metastases. -Curcumin, a novel small-molecular-weight compound, has been shown to inhibit carcinogenesis in different organs and the common link between these actions is its antiangiogenic effect.
Sulochana S, Bhandarkar, Jack L, Arbiser
openaire   +2 more sources

Angiogenesis and angiogenesis inhibitors in cancer.

Forum (Genoa, Italy), 1999
Angiogenesis, the development of a new blood supply, is an essential process of tumour growth and metastasis. Over the past few years, this has led to the consideration of the tumour vasculature as an optimal target for anti-cancer strategies. The process of angiogenesis consists of a series of interactive events: quiescent endothelial cells are ...
R, Giavazzi, G, Taraboletti
openaire   +1 more source

Combining Angiogenesis Inhibitors with Radiation: Advances and Challenges in Cancer Treatment

Current Pharmaceutical Design, 2021
Ashwini Prabhu
exaly  

Angiogenesis Inhibitors: Current Strategies and Future Prospects

Ca-A Cancer Journal for Clinicians, 2010
Kristina M Cook
exaly